Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
about
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@en
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@nl
type
label
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@en
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@nl
prefLabel
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@en
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@nl
P2093
P2860
P356
P1476
Use of clinical next-generatio ...... s harboring SMARCB1 mutations.
@en
P2093
Alan E Siroy
Carlos A Torres-Cabala
David L Stockman
Ian R Watson
Jennifer A Wargo
Jonathan L Curry
Keyur P Patel
Mark A Routbort
Michael A Davies
P2860
P304
P356
10.1111/CUP.12481
P577
2015-03-24T00:00:00Z